<VariationArchive VariationID="11549" VariationName="NM_001159699.2(FHL1):c.428_430dup (p.Phe143_Thr144insIle)" VariationType="Duplication" Accession="VCV000011549" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-03-11" DateCreated="2013-04-04" MostRecentSubmission="2024-03-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26588" VariationID="11549">
      <GeneList>
        <Gene Symbol="FHL1" FullName="four and a half LIM domains 1" GeneID="2273" HGNC_ID="HGNC:3702" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136146702" stop="136211359" display_start="136146702" display_stop="136211359" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135228860" stop="135293517" display_start="135228860" display_stop="135293517" Strand="+" />
          </Location>
          <OMIM>300163</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001159699.2(FHL1):c.428_430dup (p.Phe143_Thr144insIle)</Name>
      <CanonicalSPDI>NC_000023.11:136207839:TCA:TCATCA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136207839" stop="136207840" display_start="136207839" display_stop="136207840" variantLength="3" positionVCF="136207839" referenceAlleleVCF="T" alternateAlleleVCF="TTCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135289998" stop="135289999" display_start="135289998" display_stop="135289999" variantLength="3" positionVCF="135289998" referenceAlleleVCF="T" alternateAlleleVCF="TTCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.135289999_135290001dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.135289999_135290001dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.136207840_136207842dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.136207840_136207842dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015895.1" sequenceAccession="NG_015895" sequenceVersion="1" change="g.65441_65443dup">
            <Expression>NG_015895.1:g.65441_65443dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159699.2" sequenceAccession="NM_001159699" sequenceVersion="2" change="c.428_430dup" MANESelect="true">
            <Expression>NM_001159699.2:c.428_430dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153171.1" sequenceAccession="NP_001153171" sequenceVersion="1" change="p.Phe143_Thr144insIle">
            <Expression>NP_001153171.1:p.Phe143_Thr144insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159700.2" sequenceAccession="NM_001159700" sequenceVersion="2" change="c.380_382dup">
            <Expression>NM_001159700.2:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153172.1" sequenceAccession="NP_001153172" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001153172.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159701.2" sequenceAccession="NM_001159701" sequenceVersion="2" change="c.467_469dup">
            <Expression>NM_001159701.2:c.467_469dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153173.1" sequenceAccession="NP_001153173" sequenceVersion="1" change="p.Phe156_Thr157insIle">
            <Expression>NP_001153173.1:p.Phe156_Thr157insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159702.3" sequenceAccession="NM_001159702" sequenceVersion="3" change="c.380_382dup" MANEPlusClinical="true">
            <Expression>NM_001159702.3:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153174.1" sequenceAccession="NP_001153174" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001153174.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159703.2" sequenceAccession="NM_001159703" sequenceVersion="2" change="c.380_382dup">
            <Expression>NM_001159703.2:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153175.1" sequenceAccession="NP_001153175" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001153175.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001159704.1" sequenceAccession="NM_001159704" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001159704.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001153176.1" sequenceAccession="NP_001153176" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001153176.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001167819.1" sequenceAccession="NM_001167819" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001167819.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001161291.1" sequenceAccession="NP_001161291" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001161291.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330659.2" sequenceAccession="NM_001330659" sequenceVersion="2" change="c.428_430dup">
            <Expression>NM_001330659.2:c.428_430dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317588.1" sequenceAccession="NP_001317588" sequenceVersion="1" change="p.Phe143_Thr144insIle">
            <Expression>NP_001317588.1:p.Phe143_Thr144insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369326.1" sequenceAccession="NM_001369326" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001369326.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356255.1" sequenceAccession="NP_001356255" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356255.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369327.2" sequenceAccession="NM_001369327" sequenceVersion="2" change="c.380_382dup">
            <Expression>NM_001369327.2:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356256.1" sequenceAccession="NP_001356256" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356256.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369328.1" sequenceAccession="NM_001369328" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001369328.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356257.1" sequenceAccession="NP_001356257" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356257.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369329.1" sequenceAccession="NM_001369329" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001369329.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356258.1" sequenceAccession="NP_001356258" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356258.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369330.1" sequenceAccession="NM_001369330" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001369330.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356259.1" sequenceAccession="NP_001356259" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356259.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369331.1" sequenceAccession="NM_001369331" sequenceVersion="1" change="c.380_382dup">
            <Expression>NM_001369331.1:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356260.1" sequenceAccession="NP_001356260" sequenceVersion="1" change="p.Phe127_Thr128insIle">
            <Expression>NP_001356260.1:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001449.5" sequenceAccession="NM_001449" sequenceVersion="5" change="c.380_382dup">
            <Expression>NM_001449.5:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001440.2" sequenceAccession="NP_001440" sequenceVersion="2" change="p.Phe127_Thr128insIle">
            <Expression>NP_001440.2:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027621.2" sequenceAccession="NR_027621" sequenceVersion="2" change="n.791_793dup">
            <Expression>NR_027621.2:n.791_793dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_739" sequenceAccession="LRG_739">
            <Expression>LRG_739:g.65441_65443dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_739t1" sequenceAccession="LRG_739t1">
            <Expression>LRG_739t1:c.428_430dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_739p1" sequenceAccession="LRG_739p1" change="p.Phe143_Thr144insIle">
            <Expression>LRG_739p1:p.Phe143_Thr144insIle</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_739t2" sequenceAccession="LRG_739t2">
            <Expression>LRG_739t2:c.380_382dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_739p2" sequenceAccession="LRG_739p2" change="p.Phe127_Thr128insIle">
            <Expression>LRG_739p2:p.Phe127_Thr128insIle</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300163.0003" DB="OMIM" />
        <XRef Type="rs" ID="1603271580" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001159699.2(FHL1):c.428_430dup (p.Phe143_Thr144insIle) AND X-linked myopathy with postural muscle atrophy" Accession="RCV000012305" Version="17">
        <ClassifiedConditionList TraitSetID="3153">
          <ClassifiedCondition DB="MedGen" ID="C2678055">X-linked myopathy with postural muscle atrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001159699.2(FHL1):c.428_430dup (p.Phe143_Thr144insIle) AND X-linked scapuloperoneal muscular dystrophy" Accession="RCV000022828" Version="21">
        <ClassifiedConditionList TraitSetID="3152">
          <ClassifiedCondition DB="MedGen" ID="C2678061">X-linked scapuloperoneal muscular dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-10-01" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2024-03-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18179888</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21629301</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3153" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3423" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked myopathy with postural muscle atrophy</ElementValue>
                <XRef ID="MONDO:0010401" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XMPMA</ElementValue>
                <XRef Type="MIM" ID="300696" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">FHL1-Related Myofibrillar Myopathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Emery-Dreifuss muscular dystrophy (EDMD) is characterized by the clinical triad of: joint contractures that begin in early childhood; slowly progressive muscle weakness and wasting initially in a humero-peroneal distribution that later extends to the scapular and pelvic girdle muscles; and cardiac involvement that may manifest as palpitations, presyncope and syncope, poor exercise tolerance, and congestive heart failure along with variable cardiac rhythm disturbances. Age of onset, severity, and progression of muscle and cardiac involvement demonstrate both inter- and intrafamilial variability. Clinical variability ranges from early onset with severe presentation in childhood to late onset with slow progression in adulthood. In general, joint contractures appear during the first two decades, followed by muscle weakness and wasting. Cardiac involvement usually occurs after the second decade and respiratory function may be impaired in some individuals.</Attribute>
                <XRef ID="NBK1436" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17081" />
                <XRef ID="17081" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301609</ID>
                <ID Source="BookShelf">NBK1436</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <XRef ID="178461" DB="Orphanet" />
              <XRef ID="C2678055" DB="MedGen" />
              <XRef ID="MONDO:0010401" DB="MONDO" />
              <XRef Type="MIM" ID="300696" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3152" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4370" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SCAPULOPERONEAL MYOPATHY, FHL1-RELATED</ElementValue>
                <XRef Type="MIM" ID="300695" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Scapuloperoneal myopathy, X-linked dominant</ElementValue>
                <XRef ID="Scapuloperoneal+myopathy/6427" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked scapuloperoneal muscular dystrophy</ElementValue>
                <XRef ID="MONDO:0010400" DB="MONDO" />
                <XRef ID="784352007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SPM</ElementValue>
                <XRef Type="MIM" ID="300695" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7608" />
                <XRef ID="7608" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FHL1-Related Myofibrillar Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173338</ID>
              </Citation>
              <XRef ID="431272" DB="Orphanet" />
              <XRef ID="C2678061" DB="MedGen" />
              <XRef ID="MONDO:0010400" DB="MONDO" />
              <XRef Type="MIM" ID="300695" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32539" SubmissionDate="2012-11-28" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300163.0003_MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY" title="FHL1, 3-BP INS, 381ATC_MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY" />
        <ClinVarAccession Accession="SCV000032539" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family of British origin with X-linked myopathy with postural muscle atrophy and generalized hypertrophy (XMPMA; 300696), Windpassinger et al. (2008) identified a 3-bp insertion after nucleotide 381 of the FHL1 gene (381_382insATC), leading to the insertion of an isoleucine residue within the second LIM domain (phe127_thr128insile). The mutation affected all 3 FHL1 isoforms.</Attribute>
              <Citation>
                <ID Source="PubMed">18179888</ID>
              </Citation>
              <XRef DB="OMIM" ID="300696" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Sarkozy et al. (2011) reported 2 additional British families with the 381delATC mutation. These 2 families and the family reported by Windpassinger et al. (2008) shared the same haplotype, consistent with a founder effect. The family reported by Windpassinger et al. (2008) included 4 males who presented in their thirties with progressive proximal muscle weakness causing walking difficulties and shoulder weakness. The disorder was progressive with at least 2 patients becoming wheelchair-bound. Other features included spinal rigidity, scapular winging, increased serum creatine kinase, and decreased vital respiratory capacity. One family reported by Sarkozy et al. (2011) included 11 affected individuals (5 women) spanning 5 generations. Three men had onset of symptoms in the second to third decade, with predominant progressive limb girdle weakness, mainly affecting the upper limbs, and scapular winging. They also had spinal rigidity and reduced lung function. An additional 3 deceased male family members were reported as being wheelchair-bound from their thirties, and dying in their late forties/early fifties of cardiorespiratory failure. Female mutation carriers had a slightly later onset of milder symptoms. In the other family reported by Sarkozy et al. (2011), 5 males spanning 4 generations were affected. One had onset in young adulthood of progressive proximal upper and lower limb weakness, foot drop, and restricted neck movements with increased serum creatine kinase. Other family members reportedly had gait difficulties. Sarkozy et al. (2011) noted the heterogeneous phenotypes in these 3 families, although they all had an overall late presentation most consistent with XMPMA. However, the involvement of women in the second family was reminiscent of X-linked dominant scapuloperoneal myopathy (300695).</Attribute>
              <Citation>
                <ID Source="PubMed">21629301</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18179888</ID>
              </Citation>
              <XRef DB="OMIM" ID="300695" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FHL1" />
          </GeneList>
          <Name>FHL1, 3-BP INS, 381ATC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS, 381ATC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300163.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="49373" SubmissionDate="2012-11-28" DateLastUpdated="2024-03-10" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300163.0003_SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT" title="FHL1, 3-BP INS, 381ATC_SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT" />
        <ClinVarAccession Accession="SCV000044117" DateUpdated="2024-03-10" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family of British origin with X-linked myopathy with postural muscle atrophy and generalized hypertrophy (XMPMA; 300696), Windpassinger et al. (2008) identified a 3-bp insertion after nucleotide 381 of the FHL1 gene (381_382insATC), leading to the insertion of an isoleucine residue within the second LIM domain (phe127_thr128insile). The mutation affected all 3 FHL1 isoforms.</Attribute>
              <Citation>
                <ID Source="PubMed">18179888</ID>
              </Citation>
              <XRef DB="OMIM" ID="300696" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Sarkozy et al. (2011) reported 2 additional British families with the 381delATC mutation. These 2 families and the family reported by Windpassinger et al. (2008) shared the same haplotype, consistent with a founder effect. The family reported by Windpassinger et al. (2008) included 4 males who presented in their thirties with progressive proximal muscle weakness causing walking difficulties and shoulder weakness. The disorder was progressive with at least 2 patients becoming wheelchair-bound. Other features included spinal rigidity, scapular winging, increased serum creatine kinase, and decreased vital respiratory capacity. One family reported by Sarkozy et al. (2011) included 11 affected individuals (5 women) spanning 5 generations. Three men had onset of symptoms in the second to third decade, with predominant progressive limb girdle weakness, mainly affecting the upper limbs, and scapular winging. They also had spinal rigidity and reduced lung function. An additional 3 deceased male family members were reported as being wheelchair-bound from their thirties, and dying in their late forties/early fifties of cardiorespiratory failure. Female mutation carriers had a slightly later onset of milder symptoms. In the other family reported by Sarkozy et al. (2011), 5 males spanning 4 generations were affected. One had onset in young adulthood of progressive proximal upper and lower limb weakness, foot drop, and restricted neck movements with increased serum creatine kinase. Other family members reportedly had gait difficulties. Sarkozy et al. (2011) noted the heterogeneous phenotypes in these 3 families, although they all had an overall late presentation most consistent with XMPMA. However, the involvement of women in the second family was reminiscent of X-linked dominant scapuloperoneal myopathy (300695).</Attribute>
              <Citation>
                <ID Source="PubMed">21629301</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">18179888</ID>
              </Citation>
              <XRef DB="OMIM" ID="300695" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FHL1" />
          </GeneList>
          <Name>FHL1, 3-BP INS, 381ATC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP INS, 381ATC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300163.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32539" TraitType="Disease" MappingType="Name" MappingValue="MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY" MappingRef="Preferred">
        <MedGen CUI="C2678055" Name="X-linked myopathy with postural muscle atrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="49373" TraitType="Disease" MappingType="Name" MappingValue="SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT" MappingRef="Alternate">
        <MedGen CUI="C2678061" Name="X-linked scapuloperoneal muscular dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

